Bladder Oncology Study Day

Thursday 4 December 2025 - hybrid event

What to expect

  • Apply current evidence-based approaches to bladder cancer management
  • Integrate new diagnostic and therapeutic strategies into clinical practice
  • Enhance multidisciplinary team collaboration
  • Improve patient counselling and shared decision-making

Sponsors

This event is supported by the following companies, who have had no input into the agenda, topics or choice of speakers, unless where specified in the programme.

Bronze sponsors

The logo for MSD.

The logo for Merck.

Bladder Oncology Study Day - Thursday 4 December 2026

Time Talk
08:45 Registration
09:00 Welcome to the day
Dr Martin Swinton, Doctor ST in Clinical Oncology, The Christie NHS Foundation Trust
09:15 Bladder Cancer Referrals And Diagnosis
Mr Amar Mohee, Consultant Urological Surgeon, University of Manchester
10:00 Non-Muscle Invasive Bladder Cancer
Mr James Dyer, Consultant Urologist, Stockport NHS Foundation Trust

10:45 - break

Time Talk
11:15 Surgery Or Radiotherapy For Bladder Cancer – The Great Debate
Yeepei Song, Consultant, The Christie NHS Foundation Trust
12:00 How Do I Decide Surgery Or Radiotherapy? – A Patient’s Perspective
Patient speaker

12:45 - lunch

Time Talk
13:30 Metastatic Bladder Cancer: Immunotherapy And EV
Kate O’Connor, Uro-Oncology Advanced Clinical Practitioner, The Christie NHS Foundation Trust
14:15 Bladder Cancer Chemotherapy: Neo-adjuvant, Metastatic And Radiosensitisers
Dr Andrew Hudson, Consultant, The Christie NHS Foundation Trust

15:00 - break

Time Talk
15:15 Managing Side Effects Of Bladder Cancer (Urostomy, Nephrostomy, Haematuria)
Mandy Bell, Lead Macmillan Urology CNS, The Christie NHS Foundation Trust
16:00 Round Up And Close
Dr Martin Swinton, Doctor ST in Clinical Oncology, The Christie NHS Foundation Trust

Last updated: November 2025